Dr. Kohif is the Founder and CEO of Kohif PharmaGenix, a company committed to revolutionizing healthcare through advanced precision medicine. With over a decade of experience in clinical pharmacy and a current professorship at the University of Florida, Dr. Kohif offers a unique blend of academic expertise and industry innovation. He holds certifications in Genetics and Precision Oncology from Harvard Medical School and is deeply dedicated to breaking down barriers in the implementation of pharmacogenomics (PGx) and precision medicine. His vision is to reshape the future of healthcare by leveraging cutting-edge technologies to deliver more personalized, efficient, and impactful patient care.
Dr. Mostafa Kohif, PharmD, MSc
CEO & Founder
Leticia Shea, PharmD, MS, BCACP
Advisory Board Member, KOHIF Pharmagenix
Dr. Leticia Shea is a consultant pharmacist and academic leader with a career spanning clinical practice, scientific communications, and pharmacogenetics education. As a Professor of Pharmacy at Regis University, she has developed innovative pharmacotherapy and pharmacogenetics courses, integrating research and technology to enhance learning and patient care. Dr. Shea’s expertise includes best practices in medication management, precision medicine, pharmacovigilance, and project management, with a proven record of driving process improvements and fostering collaboration among healthcare professionals. Her clinical work at HealthOne Physician Services Group has focused on optimizing medication access, developing clinical decision support tools, and significantly improving medication adherence and safety.
She has authored over 29 peer-reviewed publications and delivered 45 conference presentations, contributing to advancements in medication safety, pharmacogenomics, and health outcomes research. Dr. Shea holds a PharmD from the University of Colorado and an MS in Pharmacogenomics and Precision Medicine from the University of Florida. Her commitment to evidence-based practice and patient-centered care makes her a valued advisor in the evolving field of pharmacogenetics.
Jolene brings a dynamic frontline perspective to the KOHIF Pharmagenix Advisory Board, drawing from her extensive experience as an Emergency Nurse Practitioner in both urban and rural hospital systems. Board-certified in emergency medicine with dual licensed as a Family Nurse Practitioner and Adult-Gerontology Acute Care Nurse Practitioner, Jolene has firsthand insight into the real-time challenges of medication management in high-acuity settings.
While new to the field of pharmacogenomics, her passion for delivering individualized, evidence-based care aligns seamlessly with Pharmagenix’s mission to optimize therapy through genetic insight. Jolene’s leadership is grounded in a deep commitment to improving patient outcomes, clinical workflow, and provider decision-making—particularly when time and clarity are critical.
Her role on the Advisory Board reflects the company’s dedication to incorporating voices from the bedside into the strategic expansion of PGx in practice. With a strong foundation in acute care and a vision for personalized medicine, Jolene serves as a vital bridge between innovation and clinical reality.
Jolene Donald, MSN, APRN, FNP-C, AGACNP-BC, ENP-C
Advisory Board Member, KOHIF Pharmagenix
Leticia Shea, PharmD, MS, BCACP
Advisory Board Member, KOHIF Pharmagenix
Dr. Leticia Shea is a consultant pharmacist and academic leader with a career spanning clinical practice, scientific communications, and pharmacogenetics education. As a Professor of Pharmacy at Regis University, she has developed innovative pharmacotherapy and pharmacogenetics courses, integrating research and technology to enhance learning and patient care. Dr. Shea’s expertise includes best practices in medication management, precision medicine, pharmacovigilance, and project management, with a proven record of driving process improvements and fostering collaboration among healthcare professionals. Her clinical work at HealthOne Physician Services Group has focused on optimizing medication access, developing clinical decision support tools, and significantly improving medication adherence and safety.
She has authored over 29 peer-reviewed publications and delivered 45 conference presentations, contributing to advancements in medication safety, pharmacogenomics, and health outcomes research. Dr. Shea holds a PharmD from the University of Colorado and an MS in Pharmacogenomics and Precision Medicine from the University of Florida. Her commitment to evidence-based practice and patient-centered care makes her a valued advisor in the evolving field of pharmacogenetics.
Shaping the Future of Healthcare and Innovation
Shaping the Future of
Healthcare and Innovation
The dedication and expertise of our leadership team are what drive Kohif Pharmagenix forward. Together, they combine a passion for innovation, excellence, and personalized care, ensuring that we continue to revolutionize patient treatment and contribute meaningfully to the future of healthcare. With a shared commitment to cutting-edge technology, patient-centric solutions, and transformative growth, they are the guiding force behind our company’s success.
We are excited about the future and invite you to join us as we continue to push the boundaries of what’s possible. If you have any questions or would like to learn more, feel free to get in touch with us.